Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: This is an important statement, Ads

Meant to get back to you on this as it was included in my Odds/Ends post on yahoo. The "termination" was of the prior anti-dilution agreement. Which agreed that any shares issued to anyone other than S/L would be dilutive to you and I but not to S/L as they would gain up to 30% of those shares issued. Who agreed to that beauty?

The date of May 31st is odd. Something like 19 1/2 months. Could it be that they actually were planning to exit fully and were timing it to the expected time frame of J's trial and this past 10Q? Certainly wouln't have gotten the expected rise in SP and could now be holding shares longer than expected. They were certainly "lucky" to sell what shares they did between the settlement and the 10Q, weren't they? Who knows? joe


May 08, 2008 04:00AM
1
May 08, 2008 04:10AM

May 08, 2008 06:20AM
Share
New Message
Please login to post a reply